Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome

Phytocannabinoids, including the non-addictive cannabis component cannabidivarin (CBDV), have been reported to hold therapeutic potential in several neurodevelopmental disorders (NDDs). Nonetheless, the therapeutic value of phytocannabinoids for treating Fragile X syndrome (FXS), a major NDD, remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Premoli, Marika, Fyke, William, Bellocchio, Luigi, Lemaire, Valerie, Wolley-Roberts, Marie, Bontempi, Bruno, Pietropaolo, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416983/
https://www.ncbi.nlm.nih.gov/pubmed/37566006
http://dx.doi.org/10.3390/cells12151927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416983/
https://www.ncbi.nlm.nih.gov/pubmed/37566006
http://dx.doi.org/10.3390/cells12151927

Ejemplares similares